Parvovirus B19 infection preceding the diagnosis of childhood myelodysplastic syndrome with low blasts: a case report
-
By
-
Leah Klingel
-
Stefanie Huber
-
Irith Baumann
-
Stephan Schwarz-Furlan
-
Almut Meyer-Bahlburg
-
Holger Lode
-
June 5, 2026
-
Clinical Scorecard: A Case Study of Parvovirus B19 Infection Prior to the Diagnosis of Myelodysplastic Syndrome with Low Blasts in a Child
At a Glance
| Category | Detail |
| Condition | |
| Key Mechanisms | Parvovirus B19 selectively targets erythroid progenitor cells, leading to suppression of erythropoiesis. |
| Target Population | Children with acute PVB19 infection. |
| Care Setting | |
Key Highlights
- PVB19 infection can cause transient bone marrow suppression.
- Pancytopenia with hypocellular marrow is uncommon in children.
Guideline-Based Recommendations
Diagnosis
- Confirm acute PVB19 infection with serologic testing.
Management
- Consider allogeneic hematopoietic stem cell transplantation for patients with myelodysplastic syndromes.
Monitoring & Follow-up
- Follow-up of bone marrow and viral load in patients post-transplant.
Risks
- Monitor for complications such as febrile pneumonitis.
Patient & Prescribing Data
Management of myelodysplastic syndrome with stem cell transplantation.
Clinical Best Practices
- Evaluate to exclude causes of pancytopenia.
- Differentiate between transient virus-associated suppression and clonal diseases.
Related Resources & Content